Press-release for stocks related to genetown

Prices are updated after-hours

tags : Genetown crawled time : 12:30

save search

Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results
Published: 2024-03-22 (Crawled : 12:30) - biospace.com/
XBIO | $4.14 7.32% 770

Health Technology

| 6.33% | O: -7.59% H: 8.6% C: 5.75%
year financial results

Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
Published: 2024-03-21 (Crawled : 12:30) - biospace.com/
CRL | $226.78 -0.34% 0.0% 410K

Commercial Services

| -15.43% | O: 0.68% H: 1.71% C: 1.27%
extension therapy

Kymera Therapeutics Announces First Patient Dosed in Phase 2 Hidradenitis Suppurativa Clinical Trial of KT-474
Published: 2023-10-27 (Crawled : 12:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -11.93% | O: -18.18% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -12.87% | O: -15.73% H: 0.0% C: 0.0%
KYMR | $33.965 -3.29% -3.4% 630K

Health Technology

| 195.13% | O: 0.78% H: 0.0% C: -5.43%
kt-474 trial therapeutics phase 2

ImmunoGen Announces European Medicines Agency Acceptance of Marketing Authorization Application for Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
Published: 2023-10-27 (Crawled : 12:30) - biospace.com/
IMGN | $31.23 0.03% 49M

Health Technology

| 124.99% | O: 7.45% H: 3.38% C: 0.54%
authorization cancer mirvetuximab application

Stoke Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference
Published: 2023-09-21 (Crawled : 12:30) - biospace.com/
STOK | $12.08 3.69% 3.56% 1M

Health Technology

| 171.4% | O: -0.23% H: 0.0% C: -6.32%
conference global therapeutics

Akili Releases EndeavorOTC™ on Android™ Devices, Expanding Treatment Access for Millions of Adults with ADHD
Published: 2023-09-21 (Crawled : 12:30) - biospace.com/
AKLI | $0.239 2.93% 2.85% 50K

| -63.09% | O: -1.52% H: 1.34% C: -14.76%
treatment adhd

Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica
Published: 2023-09-14 (Crawled : 12:30) - biospace.com/
CRL | $226.78 -0.34% 0.0% 410K

Commercial Services

| 11.38% | O: 1.1% H: 1.12% C: 0.93%
drug sciences collaboration

Haemonetics Announces European Expansion for VASCADE® Vascular Closure System
Published: 2023-08-29 (Crawled : 12:30) - biospace.com/
HAE | $81.24 -2.66% -1.65% 850K

Health Technology

| -8.07% | O: -0.02% H: 1.38% C: 1.37%
vascade expansion system

Scholar Rock Presents Data Analysis of Multiple Efficacy Endpoints from the Apitegromab TOPAZ Phase 2 Trial at the American Academy of Neurology 2022 Annual Meeting
Published: 2022-03-22 (Crawled : 12:30) - biospace.com/
SRRK 4 | $13.85 -0.72% -0.72% 710K

Health Technology

| 14.46% | O: 0.99% H: 8.51% C: 6.3%
trial phase 2

NeuroBo Pharmaceuticals, Inc. Expands Scientific Advisory Board with Appointment of Danamarie Belpulsi, M.D.
Published: 2022-03-15 (Crawled : 12:30) - biospace.com/
CTLT | $55.48 -0.57% -0.4% 1.6M

Health Technology

| -42.0% | O: 1.08% H: 0.67% C: -0.11%
NRBO | $3.325 -3.34% -3.46% 21K

Health Technology

| 364.83% | O: -0.69% H: 16.67% C: 7.28%
ICLR | $288.32 -1.2% -1.21% 640K

Health Technology

| 31.68% | O: 0.13% H: 2.13% C: 1.89%
als

CAMP4 Therapeutics Appoints Veteran Drug Developer Ann Barbier, M.D., Ph.D. as Chief Medical Officer
Published: 2022-03-14 (Crawled : 12:30) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -12.72% | O: 0.91% H: 0.0% C: 0.0%
drug therapeutics

ImmunoGen to Present Full Results from SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer at the Society of Gynecologic Oncology Annual Meeting
Published: 2022-03-10 (Crawled : 12:30) - biospace.com/
IMGN | $31.23 0.03% 49M

Health Technology

| 476.38% | O: 1.29% H: 4.37% C: -0.18%
ovarian cancer trial results cancer mirvetuximab

Akili to Speak on Integrating Digital Therapeutics Into Mainstream Healthcare at DTx West 2022
Published: 2022-02-18 (Crawled : 12:30) - biospace.com/
DNAA 4 | $14.07 198.51%

| -2.84% | O: 0.05% H: 0.15% C: 0.15%
health thc therapeutics

Alofisel®▼ (darvadstrocel) Shows Clinical Remission Rate at Six-Months in the Real-World INSPIRE Study Interim Analysis Consistent with the Pivotal Clinical ADMIRE-CD Study1,2
Published: 2022-02-18 (Crawled : 12:30) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M

Health Technology

| -13.24% | O: 0.13% H: 0.52% C: 0.46%
alofisel cel

AlloVir Reports Full-Year 2021 Financial Results and 2022 Outlook
Published: 2022-02-10 (Crawled : 12:30) - biospace.com/
ALVR | $0.7505 1.13% 1.12% 340K

Health Technology

| -90.96% | O: -2.53% H: 12.36% C: 4.57%
financial results report results

GentiBio Appoints Industry Veteran Chuck Silberstein as Chief Financial Officer
Published: 2022-02-10 (Crawled : 12:30) - biospace.com/
IBIO | $1.72 -2.83% 0.0% 95K

Health Technology

| 314.16% | O: -1.04% H: 2.19% C: -5.11%

Arkuda Therapeutics Raises $64 Million Series B Financing to Advance Pipeline of Programs Targeting Lysosomal Biology to Treat Neurodegenerative Diseases
Published: 2022-02-10 (Crawled : 12:30) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 200.89% | O: -0.69% H: 0.0% C: 0.0%
program therapeutics disease neurodegenerative

Oak Hill Bio Launches With Pipeline and Senior Leadership From Takeda
Published: 2022-02-01 (Crawled : 12:30) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M

Health Technology

| -7.93% | O: 0.07% H: 1.53% C: 1.32%
GSK | News | $39.75 1.22% 0.0% 1.6M

Health Technology

| -11.27% | O: 0.45% H: 0.53% C: 0.42%

Bruker Acquires Prolab Instruments to Augment Multiomics Solutions
Published: 2022-01-19 (Crawled : 12:30) - biospace.com/
BRKR | $77.725 -1.06% -1.07% 1.3M

Health Technology

| 11.98% | O: 0.03% H: 0.76% C: -1.48%